Search research articles
Contact Us
Filters
Showing results (201-210 of 387) with videos related to
Page
of 39
Sort By:
Nature Reviews. Drug Discovery
|
August 1, 2023
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A Akdis, Mübeccel Akdis, et al.
Journal of the American Academy of Dermatology
|
May 7, 2023
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort
Jonathan I Silverberg, Brenda Simpson, Katrina Abuabara, et al.
Archives of Dermatological Research
|
July 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
The Journal of Investigative Dermatology
|
November 20, 2025
Ruxolitinib cream demonstrated rapid reductions in itch and atopic dermatitis signs that correlated with biomarkers
Robert Bissonnette, Etienne Saint-Cyr Proulx, Joel Correa da Rosa, et al.
Advances in Therapy
|
August 28, 2025
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease
Gerd R Burmester, Atul Deodhar, Alan D Irvine, et al.
The Journal of Allergy and Clinical Immunology
|
February 10, 2020
Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis
Helen He, Hemant Suryawanshi, Pavel Morozov, et al.
Archives of Dermatological Research
|
November 13, 2018
A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Ana Pavel, Christopher Yao, et al.
Allergy
|
March 15, 2021
An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata
Jacob W Glickman, Celina Dubin, Dante Dahabreh, et al.
Allergy
|
July 14, 2024
Evolution of pathologic B-cell subsets and serum environment-specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood
Tali Czarnowicki, Eden David, Kazuhiko Yamamura, et al.
The Journal of Allergy and Clinical Immunology
|
July 19, 2011
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response
Suzanne Tintle, Avner Shemer, Mayte Suárez-Fariñas, et al.
Page
of 39
Search research articles
Search
Showing results (201-210 of 387) with videos related to
Sort By:
Page
of 39
Nature Reviews. Drug Discovery
|
August 1, 2023
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A Akdis, Mübeccel Akdis, et al.
Journal of the American Academy of Dermatology
|
May 7, 2023
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort
Jonathan I Silverberg, Brenda Simpson, Katrina Abuabara, et al.
Archives of Dermatological Research
|
July 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
The Journal of Investigative Dermatology
|
November 20, 2025
Ruxolitinib cream demonstrated rapid reductions in itch and atopic dermatitis signs that correlated with biomarkers
Robert Bissonnette, Etienne Saint-Cyr Proulx, Joel Correa da Rosa, et al.
Advances in Therapy
|
August 28, 2025
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease
Gerd R Burmester, Atul Deodhar, Alan D Irvine, et al.
The Journal of Allergy and Clinical Immunology
|
February 10, 2020
Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis
Helen He, Hemant Suryawanshi, Pavel Morozov, et al.
Archives of Dermatological Research
|
November 13, 2018
A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
Daniela Mikhaylov, Ana Pavel, Christopher Yao, et al.
Allergy
|
March 15, 2021
An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata
Jacob W Glickman, Celina Dubin, Dante Dahabreh, et al.
Allergy
|
July 14, 2024
Evolution of pathologic B-cell subsets and serum environment-specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood
Tali Czarnowicki, Eden David, Kazuhiko Yamamura, et al.
The Journal of Allergy and Clinical Immunology
|
July 19, 2011
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response
Suzanne Tintle, Avner Shemer, Mayte Suárez-Fariñas, et al.
Page
of 39